Dishman Pharma [Merged] - Dishman Pharmaceuticals & Chemicals [Merged] Share Price

Dishman Pharma [Merged] - Dishman Pharmaceuticals & Chemicals [Merged] Share Price

Loading...
Open-
High199.00
Low186.95
Prev Close186.35
Volume3,089
VWAP(₹)-

Stock not traded on NSE/BSE

Key Metrics

PE Ratio(x)-
EPS - TTM(₹)-
MCap(₹ Cr.)-
MCap Rank-
PB Ratio(x)-
Div Yield(%)-
Face Value(₹)-
52W High(₹)-
52W Low(₹)-
MCap/Sales-
Beta(1 Month)-
BV/Share(₹)-

Dishman Pharma [Merged] share price insights

We don’t have any Insights for this stock currently.

Dishman Pharma [Merged] Share Price Returns

1 DayN.A.
1 MonthN.A.
3 MonthsN.A.
1 YearN.A.
3 YearsN.A.
5 YearsN.A.

Dishman Pharma [Merged] Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Financials

  • QuarterlyJun 2017Mar 2017Dec 2016Sep 2016Jun 2016
    Total Income344.73538.04377.60444.20382.41
    Total Income Growth (%)-35.9342.49-14.9916.16-12.10
    Total Expenses319.55444.52295.63351.66301.70
    Total Expenses Growth (%)-28.1150.36-15.9316.56-13.16
    EBIT25.1893.5281.9792.5480.71
    EBIT Growth (%)-73.0814.09-11.4214.66-7.91
    Profit after Tax (PAT)13.0242.7850.6854.6845.51
    PAT Growth (%)-69.57-15.59-7.3220.15-8.83
    EBIT Margin (%)7.3017.3821.7120.8321.11
    Net Profit Margin (%)3.787.9513.4212.3111.90
    Basic EPS (₹)0.812.653.143.392.82
    QuarterlyJun 2017Mar 2017Dec 2016Sep 2016Jun 2016
    Total Income96.19164.86107.03145.9595.99
    Total Income Growth (%)-41.6554.03-26.6752.05-33.49
    Total Expenses102.01125.9480.5688.8769.12
    Total Expenses Growth (%)-19.0056.33-9.3528.57-28.84
    EBIT-5.8238.9226.4757.0826.87
    EBIT Growth (%)-114.9547.03-53.63112.43-43.06
    Profit after Tax (PAT)-8.4820.1816.1137.758.42
    PAT Growth (%)-142.0225.26-57.32348.34-63.69
    EBIT Margin (%)-6.0523.6124.7339.1127.99
    Net Profit Margin (%)-8.8212.2415.0525.878.77
    Basic EPS (₹)-0.531.251.002.340.52

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

  • No Data Available

  • No Data Available

  • No Data Available

Found Financials useful?

Technicals

Peer Comparison

  • NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Dishman Pharma [Merged]74.150.00---0.000.00-0.001.930.580.00
    Add More stocks of your interest to compare.
    Annual Ratios (%)

    Choose from Peers

      Choose from Stocks

        • CHART
        • TABLE
        • 1D
        • 1W
        • 1M
        • 3M
        • 6M
        • 1Y
        • 5Y
        • There’s no suggested peer for this stock.

      Shareholding Pattern

      Mutual Funds Ownership

      No Data Available

      Corporate Actions

      • General Meeting

        Book closure from Sep 21, 2017 to Sep 28, 2017

        Aug 21, 2017

        Board Meeting

        Quarterly Results

        Aug 03, 2017

        Board Meeting

        Audited Results

        May 09, 2017

      • Announced onMeeting on
        Aug 03, 2017Aug 10, 2017
        Quarterly Results
        May 09, 2017May 16, 2017
        Audited Results
        Mar 17, 2017Mar 17, 2017
        Others
        Feb 08, 2017Feb 13, 2017
        Quarterly Results & Interim Dividend
        Oct 19, 2016Oct 27, 2016
        Quarterly Results
      • Announced onEx-DateDividend%
        Feb 06, 2017Feb 17, 201760%
        Mar 08, 2016Mar 17, 2016100%
        Aug 24, 2015Sep 10, 2015100%
        May 29, 2014Aug 21, 201460%
        May 28, 2013Jul 18, 201360%
      • Announced onEx-Date
        Feb 25, 2016May 02, 2016
        Bonus Ratio: 1 share(s) for every 1 shares held
      • Announced onEx-Date
        Aug 31, 2005Oct 21, 2005
        Split: Old FV10.0| New FV:2.0
      • No Data Available

      • Announced onMeeting on
        Aug 21, 2017Sep 28, 2017
        Book closure from Sep 21, 2017 to Sep 28, 2017
        Aug 31, 2016Sep 27, 2016
        Book closure from Sep 20, 2016 to Sep 27, 2016
        Jul 11, 2016Aug 05, 2016
        -
        Mar 10, 2016Apr 21, 2016
        -
        Aug 24, 2015Sep 29, 2015
        Rs.2.0000 per share(100%)Final Dividend

      About Dishman Pharma [Merged]

      Key Indices Listed On

      -

      Address

      Bhadr - Raj Chambers,Swastik Cross Road, NavrangpuraAhmedabad, Gujarat - 380009

      Executive Leadership

      No Data Available

      Auditors

      No Data Available

      FAQs about Dishman Pharma [Merged] share

      • 1. What is Dishman Pharma [Merged] share price and what are the returns for Dishman Pharma [Merged] share?
        Dishman Pharma [Merged] share price is Rs 301.05 as on 29 May, 2017, 12:00 AM IST. Dishman Pharma [Merged] share price is remain unchanged by N.A. based on previous share price of Rs. 186.35.
      • 2. What's the market capitalization of Dishman Pharma [Merged]?
        Dishman Pharma [Merged] share has a market capitalization of Rs 4,858.77 Cr. Within Miscellaneous sector, it's market cap rank is -.
      • 3. What is 52 week high/low of Dishman Pharma [Merged] share price?
        52 Week high of Dishman Pharma [Merged] share is Rs 346.25 while 52 week low is Rs 127.60

      Top Gainers

      As on 04:06 PM | 12 Jun 2026
      Ather Energy
      1,028.70
      714.90 (227.82%)
      Netweb Technologies
      4,587.40
      2780.60 (153.90%)
      Syrma SGS Technology
      1,266.70
      737.70 (139.45%)
      Vodafone Idea
      14.90
      8.12 (119.76%)
      GE T&D India
      4,942.50
      2633.90 (114.09%)

      Top Losers

      As on 03:58 PM | 12 Jun 2026
      Tata Investment
      665.90
      -6218.10 (-90.33%)
      Angel One
      339.50
      -2678.10 (-88.75%)
      CAMS
      757.55
      -3315.15 (-81.40%)
      Kotak Bank
      403.30
      -1723.50 (-81.04%)
      Authum Investment
      530.15
      -1967.65 (-78.78%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.